By the Peptide Marketing team, iComChain LLC · Last updated: 16 November 2026
Peptide remarketing is harder than remarketing for an ordinary online store. If Google treats your ads or site as health-related or as promoting prescription drug terms, its personalized advertising policy stops you using your own audience lists, and Meta can restrict the data your pixel sends. This guide is for owners and marketers of research-use-only (RUO) peptide stores. It explains which audience types are affected on Google and Meta, how Customer Match eligibility works, what Performance Max does with audience signals, why email and SMS carry most of the load, and how to tell whether remarketing adds sales at all. It is general information, not legal advice, and it contains no dosing, efficacy or human-use information.
- Google’s rule is about what you promote. Advertisers promoting in a sensitive interest category, including Health and Restricted drug terms, cannot use advertiser-curated audiences such as website visitors, Customer Match or lookalikes.
- Google’s own audiences stay open. Predefined audiences such as affinity and in-market segments can still be used, because Google excludes sensitive signals from them.
- Customer Match has its own gate. Full targeting needs good compliance and payment history, 90 days of account history and more than USD 50,000 lifetime spend.
- Meta restricts the data, not just the ad. A health and wellness data source category can limit lower-funnel events, and flagged custom audiences cannot be used.
- Owned channels do the real remarketing. Consented email and SMS lists are yours, and they are where most follow-up should happen.
- Measure lift, not attributed sales. Remarketing audiences buy anyway at high rates; only a holdout test shows what the ads added.
- Google’s personalized advertising policy
- Which audience types are affected
- Customer Match eligibility
- Meta’s limits on health-related audiences
- Remarketing inside Performance Max
- Owned-channel remarketing: email and SMS
- Frequency and creative rules
- Measuring incrementality
- The remarketing setup checklist
- FAQ
- Sources
1. Google’s personalized advertising policy
Google’s Restricted targeting in Personalized advertising policy lists sensitive interest categories. Two matter most for peptide stores:
- Health. This covers physical or mental health conditions, products to treat or manage chronic conditions, and invasive procedures, with injections named as an example.
- Restricted drug terms. This covers prescription medications and information about them. Content aimed at healthcare professionals is excluded in the US, Canada and New Zealand, but only for advertisers who hold the separate personalization certification.
The consequence is the same for both: “Advertisers promoting products and services that fall within sensitive interest categories are unable to use advertiser-curated audiences.” Predefined Google audiences remain available, because Google says sensitive user signals are excluded from them. Users under 18 receive no personalized ads of any kind.
Google also does not let you use a negative list as a back door. The policy says advertisers “must not use negative remarketing lists for positive personalization”, and it bans data segments that target an overly narrow audience, including when combined with tight location targeting.
Google classifies ads and destinations, not business models, and the research-use label does not decide it. A compound that shares a name with an approved drug’s active ingredient is a prescription drug term. Pages that read as treatment, injection or condition content fit the Health description. Our working assumption is that remarketing lists may be restricted at any time, so we plan campaigns that still work without them. If ads are flagged, Google’s first listed fix is to remove the advertiser-curated audiences, and that is the fix to use.
The policy applies on top of everything else. Google’s Healthcare and medicines policy still decides whether a product may be advertised at all. Our guide on which peptides can be advertised covers that first step.
2. Which audience types are affected
Google now calls remarketing “your data”. Its your data segments page lists website visitors, dynamic remarketing, data segments for Search ads, YouTube users, Customer Match, app users and lead form segments. All of these are advertiser-curated, so all of them are affected if you promote in a sensitive category.
Shaded cells are restricted when your ads or site fall in a sensitive category. Policy text, not this chart, is the final word.
| Audience type | Google, sensitive category | Meta, restricted data source | What we do |
|---|---|---|---|
| Website visitors | Not allowed (your data segment) | Website custom audiences depend on events Meta may limit | Use only if ads are not in a sensitive category; remove if flagged |
| YouTube viewers | Not allowed (your data segment) | Video engagement audiences must not reflect health information | Use YouTube for reach with predefined audiences |
| Customer lists | Not allowed; Customer Match also has eligibility rules | Flagged if the list or its name implies health information | Keep lists neutral; rely on email and SMS instead |
| Lookalikes or similar | Not allowed | Flagged if the seed audience is flagged | Build from neutral seeds only, where permitted |
| Affinity and in-market | Allowed | Detailed targeting on health causes was removed in 2022 | Use broad, interest-neutral targeting |
| Email and SMS | Not an ad audience | Not an ad audience | Main remarketing channel |
Google notes that Demand Gen campaigns use advertiser-curated audiences by default and may be restricted from serving in sensitive categories. Check those first if impressions drop.
- Brand Search. Returning visitors often search your brand name. A brand campaign catches them without any audience list.
- Search and Shopping for lower-risk products. Keyword intent does the job that a remarketing list would otherwise do.
- Predefined Google audiences on YouTube and Display, used for reach rather than follow-up.
- Owned lists. Email and SMS, covered in section 6.
None of these needs a workaround, and none breaks if Google later reclassifies your ads.
3. Customer Match eligibility
Customer Match has its own policy, separate from the sensitive-category rules. Access depends on the account:
- Every account needs a good history of policy compliance and a good payment history. Without both, the account is ineligible.
- All policy-compliant accounts can use Customer Match in the Observation setting and for exclusions.
- Accounts with 90 days of history and more than USD 50,000 lifetime spend can also use the Targeting setting and manual bid adjustments.
Other rules worth knowing:
- Upload only data you collected first-party, and say in your privacy policy that you share customer data with service providers.
- List memberships expire after 540 days, and a list needs at least 100 members added or updated in that window to stay eligible.
- The policy does not allow ad content that implies knowledge of a customer’s sensitive information, or promotion of “products related to sensitive information, such as pharmaceutical products” in a Customer Match campaign.
- Google says it may remove access for any advertiser, and an account with a suspension or repeated disapprovals should not expect it. Our suspension recovery guide covers rebuilding that history.
The Customer Match policy lists exclusions as available to all compliant accounts, and excluding existing buyers from prospecting is a common use. The personalized advertising policy does not say whether exclusions count as using an advertiser-curated audience in a sensitive category. If an excluded list triggers a flag, remove it rather than appeal.
4. Meta’s limits on health-related audiences
Meta works on the data side. Its data source categories page says websites and apps may be assigned a category such as “Health and wellness”, and that some categories carry extra data sharing restrictions. Its page on restrictions by data source category lists three levels:
- Core setup. Custom parameters and the parts of URLs after the domain are not shared.
- Restriction on certain standard events. Specific mid- and lower-funnel events are blocked.
- Full restrictions. No events are shared in some or all regions, and Meta Business Tools cannot be used for ads purposes there.
For remarketing, the second and third levels matter most. If add-to-cart or purchase events cannot be shared, audiences built from them stop filling. Meta suggests upper-funnel events, or objectives that do not rely on shared data such as Awareness, Engagement and Traffic.
Audiences are policed separately. Meta’s page on restrictions on certain custom audiences says custom or lookalike audiences that include information not allowed under its terms, such as references to specific health conditions, are flagged and cannot be used. Its prohibited information page adds that audience names and criteria must not reflect or imply such information.
On targeting, Meta removed Detailed Targeting options relating to sensitive topics, including health causes, from 19 January 2022. Whether a peptide product can be advertised on Meta at all is decided by its Drugs and Pharmaceuticals standard, which you should read before any spend.
Do not choose a data source category you know is wrong, rename events to hide what they track, or send purchase data under a neutral event name. Meta says you can categorise your own data sources, but it can also assign a category you cannot change, and it treats prohibited information as a breach of its Business Tools Terms. If you think a category is wrong, use the review request in Events Manager.
5. Remarketing inside Performance Max
Performance Max has no separate remarketing switch. Google’s audience signals page lists website visitor lists, customer lists and video viewer lists as inputs, alongside custom segments and Google’s own segments. Two points follow:
- Signals are suggestions. Google says Performance Max may show ads to audiences outside your signals, so a signal never limits who sees an ad.
- Your data signals are advertiser-curated. If the campaign promotes in a sensitive category, Google’s fix is to remove them from asset groups as well as campaigns and ad groups.
A peptide Performance Max campaign should still work with signals built only from search-term custom segments and predefined Google audiences. Keep product feeds limited to items you are prepared to defend. Our Performance Max guide covers the setup, and our Google Ads and Google Shopping services build campaigns this way. Feed problems belong with Merchant Center recovery.
6. Owned-channel remarketing: email and SMS
A consented list is the one remarketing audience no ad platform can switch off. It is also where most follow-up with a peptide customer should happen.
- Build the list at checkout and with a sign-up form, with clear consent wording.
- Automate the basics: order confirmation and shipping, a browse or cart reminder, a restock alert and a periodic catalog update.
- Follow CAN-SPAM. The FTC’s compliance guide requires a valid physical postal address, a clear way to opt out, and honouring opt-outs within 10 business days.
- Keep content RUO. Emails are advertising matter. Use product names, specifications, lot and certificate links, and no outcome claims.
- Check your sending platform’s acceptable use policy before you import a list.
SMS
SMS needs explicit consent, carrier registration and a platform that accepts the category, and several do not. Our SMS marketing guide covers platform policies and what to send. Keep SMS to transactional updates and occasional offers.
Our peptide email marketing service sets up these flows, and product pages built from our product page template give every email a claim-free destination.
7. Frequency and creative rules
Frequency
Google’s frequency capping works in Display and Video campaigns. Display caps are set after the campaign is created, under Frequency management, and count only viewable impressions. Video caps are set at campaign level by impressions, views or both, per day, week or month. Frequency capping is not supported in Demand Gen. Start with a modest weekly cap and raise it only if a lift test supports it.
Creative
- Do not imply you know who the viewer is or why they visited. The Customer Match policy bars ads that imply knowledge of sensitive information, and “still thinking about it?” copy naming a compound comes close.
- Use brand and catalog messages: lab standards, certificates of analysis, shipping, support.
- Keep the same claim-free standard as your product pages. No outcomes, conditions, dosing, before-and-after imagery or syringes.
- Check dynamic remarketing feeds. Dynamic ads pull titles and images straight from the feed, so a risky product in the feed becomes a risky ad.
8. Measuring incrementality
Remarketing audiences are people who were already interested, so platform-attributed conversions overstate what the ads caused. Lift testing compares people who could see the ads with people who could not.
- Google Conversion Lift. Google’s Conversion Lift splits users or geographies into treatment and control groups and reports incremental conversions, incremental cost per action and incremental ROAS. It is not available to every account; you request it through a Google representative.
- Geo holdouts. Pause a campaign in comparable regions for a fixed period and compare sales against regions where it ran.
- Email and SMS holdouts. Keep a random share of subscribers out of a flow and compare their order rate with those who received it.
Reading the result
- Lift close to zero means the audience would have bought anyway. Move the budget to prospecting or cut it.
- Positive lift with a high incremental cost per action means the ads help but cost too much. Lower the frequency cap or narrow the window before you scale.
- Inconclusive results usually mean too few conversions. Run the test longer or test a bigger share of spend, rather than reading noise as a result.
Decide the test length, success metric and holdout size before the test starts, and do not stop early on a good week. Clean conversion data matters here; our conversion tracking guide covers GA4, enhanced conversions and server-side setups. Count refunds and chargebacks against the result too; if a processor switch has broken your order data, our peptide payment processing service can help steady it first.
9. The remarketing setup checklist
- Read the Health and Restricted drug terms pages and record whether your ads and destinations plausibly fall in either.
- Check Policy manager for personalized advertising flags on ads, asset groups and campaigns.
- Remove advertiser-curated audiences from any flagged campaign, ad group and asset group.
- Check Customer Match eligibility: compliance history, payment history, 90 days and USD 50,000 lifetime spend.
- Review Demand Gen campaigns, which default to advertiser-curated audiences.
- Open Meta Events Manager and record your data source category and any event restrictions.
- Rename audiences and events so none reflects a health condition or other prohibited information.
- Rebuild Performance Max signals from custom segments and predefined audiences only if needed.
- Set frequency caps on Display and Video campaigns.
- Audit remarketing creative and feeds for outcome words, compound-specific follow-up copy and product imagery.
- Confirm email and SMS consent, opt-out handling and postal address.
- Schedule a holdout test before increasing any remarketing budget.
10. FAQ
Can a peptide store run remarketing on Google Ads?
Only if its ads and destinations do not fall in a sensitive interest category such as Health or Restricted drug terms. If they do, Google does not allow advertiser-curated audiences, which include website visitors, YouTube users and Customer Match lists.
Which Google audiences can I still use?
Predefined Google audiences such as affinity, in-market, life events and demographics, plus location targeting. Google says sensitive user signals are excluded from them, so they stay available in sensitive categories.
Am I eligible for Customer Match?
You need a good policy compliance and payment history. Observation and exclusions are open to compliant accounts; targeting and bid adjustments need 90 days of history and more than USD 50,000 lifetime spend.
Why did my Meta retargeting audiences shrink?
If Meta assigned your website a health and wellness data source category, it may block mid- and lower-funnel events, so audiences built on them stop filling. Check the category in Events Manager and request a review if it is wrong.
Does Performance Max remarket automatically?
Performance Max can use your data as audience signals, but signals are suggestions and Google may show ads beyond them. In a sensitive category, remove your data signals and rely on custom segments and Google’s own audiences.
Is email a workaround to these policies?
No, it is a separate channel with its own rules. A consented list you own is not an ad audience, but CAN-SPAM, consent law and your sending platform’s policies apply, and emails must stay claim-free.
How do I know if remarketing is working?
Run a lift test. Use Google Conversion Lift if your account has it, or a geo or list holdout, and compare treated and control groups rather than trusting attributed conversions.
Check your remarketing setup before it gets flagged
Peptide Marketing works only with research-use-only peptide brands. We will review your audiences, Performance Max signals, Meta data setup and email flows, and tell you what to keep, what to remove and how to test the rest. We do not help work around platform policies.
Prefer email? Write to hello@peptidemarketing.info.
Sources
- Google Ads policy: Restricted targeting in Personalized advertising, Health in personalized advertising, Restricted drug terms in personalized advertising, Customer Match policy, Healthcare and medicines
- Google Ads Help: About your data segments, Audience signals for Performance Max, Frequency capping, About Conversion Lift
- Meta: Data source categories, Restrictions by data source category, Restrictions on certain custom audiences, Prohibited information, Removing certain ad targeting options, Drugs and Pharmaceuticals
- FTC: CAN-SPAM Act: A Compliance Guide for Business
General information for businesses selling research-use-only products, not legal or regulatory advice. Sources read on 16 November 2026; policies change.
Leave a Reply